JAVELIN PHARMACEUTICALS, INC 3 SEC Filings

Filed On	Filing
27 Feb 2008	Form 3: Kiernan Peter D. Iii, Director Holds 2,261,848 shares of Common Stock
19 Dec 2006	Form 3: Nebgen Georg, Director Holds 1,805,689 shares of Common Stock
27 Jun 2006	Form 3: Matthews Mark, VP of Commercial Affairs Holds 0 shares of Common Stock, $.001 par value
20 Jun 2006	Form 3: Bernstein David B, Secretary & General Counsel
20 Jun 2006	Form 3: Driscoll Martin J, Director Holds 0 shares of Common Stock, $.001 par value
16 Jun 2006	Form 3: Flanzraich Neil, Director Holds 0 shares of Common Stock, $.001 par value
18 May 2006	Form 3: Tulipano Stephen J, Chief Financial Officer
14 Nov 2005	Form 3: Wexford Capital Llc, 10% owner and 2 others Holds 2,568,198 shares of Common Stock
14 Jul 2005	Form 3: Peters William P, Director Holds 0 shares of Common Stock, $.001 par value
11 Jan 2005	Form 3: Kash Peter M, Director Holds 381,472 shares of Common Stock, $.001 par value
11 Jan 2005	Form 3: Clegg Jackie M, Director Holds 0 shares of Common Stock, $.001 par value
20 Dec 2004	Form 3: Rosenwald Lindsay A Md, 10% owner Holds 2,230,973 shares of Common Stock
16 Dec 2004	Form 3: Watson Douglas G, Director Holds 0 shares of Common Stock, $.001 par value
16 Dec 2004	Form 3: Mermelstein Fred H, Director Holds 552,316 shares of Common Stock, $.001 par value
16 Dec 2004	Form 3: Hamilton Douglas A, CFO & COO Holds 385,221 shares of Common Stock, $.001 par value
16 Dec 2004	Form 3: Carr Daniel B, Chief Medical Officer Holds 0 shares of Common Stock, $.001 par value
21 Dec 2001	Form 3
21 Dec 2001	Form 3

Comments